AF
UTHR icon

Amalgamated Financial’s United Therapeutics UTHR Stock Holding History

Amalgamated Financial’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$5.67M Buy
+31,584
New +$6.02M 0.05% 398

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Amalgamated Financial's UTHR Position: Q1 2022 in Review

Amalgamated Financial opened a new position in United Therapeutics (UTHR) in Q1 2022: 31,584 shares worth $5.67M. The stake represents 0.05% of the portfolio and ranks #398 among its holdings.

428 funds tracked by Wall St. Rank hold UTHR as of Q1 2022.

  • Amalgamated Financial held 31,584 shares of United Therapeutics worth $5.67M as of Q1 2022.
  • United Therapeutics was a new Amalgamated Financial position in Q1 2022.
  • United Therapeutics made up 0.05% of Amalgamated Financial's portfolio in Q1 2022, its #398 holding.
  • 428 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.